Antibody-Drug Conjugate 2D: Reaction-Diffusion Bystander…

What Are Antibody-Drug Conjugates (ADCs)?

Antibody-drug conjugates are therapeutic molecules that combine a monoclonal antibody with one or more cytotoxic drugs. These conjugates target specific antigens on cancer cells, allowing for precise delivery of the drug payload directly to the tumor site.

The key components of an ADC include the antibody (which recognizes and binds to the target antigen), the linker (a chemical bond that connects the antibody to the drug), and the cytotoxic payload (the active drug molecule).

Reaction-Diffusion Models in ADCs

Reaction-diffusion models are mathematical frameworks used to describe how substances spread through space while undergoing chemical reactions. In the context of ADCs, these models help predict how the drug payload diffuses and reacts within tumor tissue.

The model accounts for both the diffusion of ADC molecules and the subsequent release and reaction of the drug payload upon binding to target cells.

live demo · related simulation● LIVE

Bystander Effect in ADCs

The bystander effect refers to the phenomenon where non-targeted cancer cells are also killed by the released drug from an ADC that has bound to neighboring cells. This occurs because the released drug can diffuse and affect nearby cells even if they do not express the target antigen.

Understanding the bystander effect is crucial for optimizing ADC design, as it can enhance overall tumor cell killing while minimizing off-target effects.

Cleavable vs Non-Cleavable Linkers

Cleavable linkers are designed to break under certain conditions (e.g., intracellular pH or enzymes), releasing the drug payload. This allows for controlled and localized drug delivery, reducing toxicity in non-targeted cells.

Non-cleavable linkers keep the drug attached to the antibody until it binds to a target cell, after which the entire ADC is internalized and the drug is released inside the cell.

Frequently asked questions

How does the bystander effect work in ADCs?

The bystander effect occurs when the drug payload from an ADC bound to a target cell diffuses into nearby non-targeted cells, killing them as well. This is due to the diffusion of the released drug through tumor tissue.

Why are cleavable linkers important in ADCs?

Cleavable linkers allow for more precise and controlled drug delivery by breaking down inside cells, releasing the payload only where it is needed. This reduces off-target effects and enhances therapeutic efficacy.

Can all types of cancer be treated with ADCs?

Not all cancers can be effectively targeted with ADCs due to the availability of suitable antigens on tumor cells. However, ADCs have shown promise in treating various types of solid tumors and hematological malignancies.

What are some real-world applications of ADCs?

ADCs are used in clinical settings to treat a variety of cancers, including breast cancer, lymphoma, and ovarian cancer. They offer a targeted approach that can improve treatment outcomes while reducing side effects.

Try it live

Everything above runs in your browser — open Antibody-Drug Conjugate 2D: Reaction-Diffusion Bystander Model and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Antibody-Drug Conjugate 2D: Reaction-Diffusion Bystander Model simulation